Biovision
Human CellExp™ Fc gamma RIV / CD16-2, Mouse recombinant
- SKU:
- 26-P1426
- Availability:
- Usually Shipped in 5 Working Days
- Storage Temperature:
- -20ºC
- Shipping Conditions:
- Gel Pack
- Shelf Life:
- 12 months
Description
Biomolecule/Target: N/A
Synonyms: Fc gamma RIV, CD16-2, Fcgr4
Alternates names: Fc gamma RIV, CD16-2, Fcgr4
Taglines: Plays a role in promoting bone resorption by enhancing osteoclast differentiation following binding to IgG2a.
Taglines: USA
Country of Animal Origin: USA
NCBI Gene ID #.: 246256
NCBI Gene Symbol: Fcgr4
Gene Source: Mouse
Accession #: A0A0B4J1G0
Recombinant: True
Source: HEK 293 Cells
Purity by SDS-PAGE #: >90%
Assay: SDS-PAGE
Purity: N/A
Assay #2: N/A
Endotoxin Level: Less than 1.0 EU per μg by the LAL method.
Activity (Specifications/test method): N/A
Biological activity: N/A
Results: N/A
Binding Capacity: N/A
Unit Definition: N/A
Molecular Weight: This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 22.8 kDa. The protein migrates as 28-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Concentration: N/A
Appearance: Lyophilized powder
Physical form description: Lyophilized powder
Reconstitution Instructions: Reconstitute in sterile deionized water to the desired protein concentration.
Background Information: FcgR4 (Low affinity immunoglobulin gamma Fc region receptor IV) is also known as CD16-2, FcgammaRIV, receptor for the Fc region of immunoglobulin gamma. Also acts as a receptor for the Fc region of immunoglobulin epsilon. Binds with intermediate affinity to both IgG2a and IgG2b. Does not display binding to IgG1 or IgG3. Plays a role in promoting bone resorption by enhancing osteoclast differentiation following binding to IgG2a. Binds with low affinity to both the a and b allotypes of IgE. Has also been shown to bind to IgE allotype a only but not to allotype b. Binding to IgE promotes macrophage-mediated phagocytosis, antigen presentation to T cells, production of proinflammatory cytokines and the late phase of cutaneous allergic reactions.
Amino acid sequence: AA Gly 21 - Gln 203
Handling: Centrifuge the vial prior to opening.
Usage: N/A